bcbs fep glp-1 coverage 2025 Insurers resist medicare and medicaid for glp-1s Your Weight-Loss Drugs Are Next

A double-blind, placebo-controlled, randomized trial of probiotics for primary prevention of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

One of our patients, JH, achieved life-changing improvements through a conservative treatment approach using the GLP-1 medication []

PlexusDx combines compounded GLP-1 therapy with genetic insights to help you pursue weight loss safely

Petrelintide, a long-acting amylin analog, is being tested in Phase II trials and may offer improved tolerability and sustained weight loss.

Partly through these actions, GLP-1 receptor agonism was shown to reduce cardiovascular disease (CVD) in people with T2D with previous CVD or at high-risk thereof

GLP-1 medications offer metabolic benefits for many patients, but specific contraindications and risk factors determine who should not use them